Patients, n (%) |
148 |
16 (10.81) |
132 (89.19) |
|
Ethnicity, n (%) |
Caucasian |
139 (93.92) |
14 (87.5) |
125 (94.70) |
|
African |
6 (4.05) |
1 (6.25) |
5 (3.79) |
|
South American |
3 (2.03) |
1 (6.25) |
2 (1.51) |
|
Sex, n (%) |
Female |
74 (50) |
10 (62.5) |
64 (48.48) |
|
Male |
74 (50) |
6 (37.5) |
68 (51.52) |
|
Age at diagnosis, mean (SD), years |
46.28 (14.431) |
54.44 (20.970) |
45.29 (13.199) |
|
Evolution at diagnosis, median (IQR), months |
36 (72) |
42 (99) |
36 (63) |
|
Diameter, median (IQR), cm |
3 (3) |
6.4 (7.5) |
3 (2.2) |
p = 0.003 |
Site (148 tumours), n (%) |
Head and neck |
15 (10.14) |
2 (12.50) |
13 (9.85) |
|
Chest |
31 (20.95) |
4 (25.00) |
27 (20.45) |
|
Abdomen |
16 (10.81) |
1 (6.25) |
15 (11.36) |
|
Upper back |
43 (29.05) |
2 (12.5) |
41 (31.06) |
|
Lower back |
10 (6.76) |
1 (6.25) |
9 (6.82) |
|
Upper extremities |
10 (6.76) |
2 (12.50) |
8 (6.06) |
|
Lower extremities |
23 (15.54) |
4 (25.00) |
19 (14.39) |
|
Distal extremities (forearm 1, foot 5), n (%) |
6 (4.05) |
1 (6.25) |
5 (3.79) |
|
Previous scar, n (%) |
6 (4.05) |
0 (0) |
6 (4.55) |
|
Pigmented (Bednar tumour), n (%) |
3 (2.03) |
0 (0) |
3 (2.27) |
|
Recurrence, n (%) |
17 (11.49) |
8 (50) |
9 (6.82) |
p < 0.001 |